{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T12:28:49Z","timestamp":1685536129421},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2005,9,28]],"date-time":"2005-09-28T00:00:00Z","timestamp":1127865600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2006,3]]},"DOI":"10.1007\/s00296-005-0060-9","type":"journal-article","created":{"date-parts":[[2005,9,27]],"date-time":"2005-09-27T08:35:01Z","timestamp":1127810101000},"page":"416-421","source":"Crossref","is-referenced-by-count":2,"title":["Prevalence of antibodies against oxidised LDL in a cohort of 163 patients with positive anti-phospholipid antibodies and recent thrombosis"],"prefix":"10.1007","volume":"26","author":[{"given":"Henning","family":"Locht","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allan","family":"Wiik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2005,9,28]]},"reference":[{"issue":"7","key":"60_CR1","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1002\/1529-0131(199907)42:7<1309::AID-ANR1>3.0.CO;2-F","volume":"42","author":"WA Wilson","year":"1999","unstructured":"Wilson WA, Gharavi AE, Koike T, Lockshin MD, Branch DW, Piette JC et\u00a0al. (1999) International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum 42(7):1309\u20131311","journal-title":"Arthritis Rheum"},{"issue":"6","key":"60_CR2","first-page":"1104","volume":"25","author":"ML Bertolaccini","year":"1998","unstructured":"Bertolaccini ML, Atsumi T, Khamashta MA, Amengual O, Hughes GR (1998) Autoantibodies to human prothrombin and clinical manifestations in 207 patients with systemic lupus erythematosus. J Rheumatol 25(6):1104\u20131108","journal-title":"J Rheumatol"},{"issue":"9","key":"60_CR3","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1002\/1529-0131(200009)43:9<1982::AID-ANR9>3.0.CO;2-2","volume":"43","author":"T Atsumi","year":"2000","unstructured":"Atsumi T, Ieko M, Bertolaccini ML, Ichikawa K, Tsutsumi A, Matsuura E et\u00a0al. (2000) Association of autoantibodies against the phosphatidylserine- prothrombin complex with manifestations of the antiphospholipid syndrome and with the presence of lupus anticoagulant. Arthritis Rheum 43(9):1982\u20131993","journal-title":"Arthritis Rheum"},{"issue":"7","key":"60_CR4","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1212\/WNL.53.7.1523","volume":"53","author":"S Tuhrim","year":"1999","unstructured":"Tuhrim S, Rand JH, Wu X, Horowitz DR, Weinberger J, Goldman ME et\u00a0al. (1999) Antiphosphatidyl serine antibodies are independently associated with ischemic stroke. Neurology 53(7):1523\u20131527","journal-title":"Neurology"},{"issue":"8","key":"60_CR5","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1161\/01.STR.30.8.1561","volume":"30","author":"S Tuhrim","year":"1999","unstructured":"Tuhrim S, Rand JH, Wu XX, Weinberger J, Horowitz DR, Goldman ME et\u00a0al. (1999) Elevated anticardiolipin antibody titer is a stroke risk factor in a multiethnic population independent of isotype or degree of positivity. Stroke 30(8):1561\u20131565","journal-title":"Stroke"},{"issue":"6","key":"60_CR6","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1161\/01.STR.31.6.1289","volume":"31","author":"E Ahmed","year":"2000","unstructured":"Ahmed E, Stegmayr B, Trifunovic J, Weinehall L, Hallmans G, Lefvert AK. (2000) Anticardiolipin antibodies are not an independent risk factor for stroke: an incident case-referent study nested within the MONICA and Vasterbotten cohort project. Stroke 31(6):1289\u20131293","journal-title":"Stroke"},{"issue":"9","key":"60_CR7","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1161\/01.STR.29.9.1759","volume":"29","author":"V Toschi","year":"1998","unstructured":"Toschi V, Motta A, Castelli C, Paracchini ML, Zerbi D, Gibelli A. (1998) High prevalence of antiphosphatidylinositol antibodies in young patients with cerebral ischemia of undetermined cause. Stroke 29(9):1759\u20131764","journal-title":"Stroke"},{"issue":"12","key":"60_CR8","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1161\/01.STR.31.12.3067","volume":"31","author":"CD Bushnell","year":"2000","unstructured":"Bushnell CD, Goldstein LB (2000) Diagnostic testing for coagulopathies in patients with ischemic stroke. Stroke 31(12):3067\u20133078","journal-title":"Stroke"},{"issue":"8850","key":"60_CR9","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/0140-6736(93)91213-6","volume":"341","author":"O Vaarala","year":"1993","unstructured":"Vaarala O, Alfthan G, Jauhiainen M, Leirisalo-Repo M, Aho K, Palosuo T (1993) Crossreaction between antibodies to oxidised low-density lipoprotein and to cardiolipin in systemic lupus erythematosus. Lancet 341(8850):923\u2013925","journal-title":"Lancet"},{"issue":"7","key":"60_CR10","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1093\/rheumatology\/37.7.746","volume":"37","author":"FJ Tinahones","year":"1998","unstructured":"Tinahones FJ, Cuadrado MJ, Khamashta MA, Mujic F, Gomez-Zumaquero JM, Collantes E et\u00a0al. (1998) Lack of cross-reaction between antibodies to beta2-glycoprotein-I and oxidized low-density lipoprotein in patients with antiphospholipid syndrome. Br J Rheumatol 37(7):746\u2013749","journal-title":"Br J Rheumatol"},{"issue":"9","key":"60_CR11","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1093\/rheumatology\/36.9.964","volume":"36","author":"O Amengual","year":"1997","unstructured":"Amengual O, Atsumi T, Khamashta MA, Tinahones F, Hughes GR (1997) Autoantibodies against oxidized low-density lipoprotein in antiphospholipid syndrome. Br J Rheumatol 36(9):964\u2013968","journal-title":"Br J Rheumatol"},{"issue":"7","key":"60_CR12","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1191\/0961203303lu400oa","volume":"12","author":"E Matsuura","year":"2003","unstructured":"Matsuura E, Kobayashi K, Koike T, Shoenfeld Y, Khamashta MA, Hughes GR (2003) Oxidized low-density lipoprotein as a risk factor of thrombosis in antiphospholipid syndrome. Lupus 12(7):550\u2013554","journal-title":"Lupus"},{"issue":"4","key":"60_CR13","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1093\/ajcp\/94.4.476","volume":"94","author":"EN Harris","year":"1990","unstructured":"Harris EN (1990) Special report. The Second International Anti-cardiolipin Standardization Workshop\/the Kingston Anti-Phospholipid Antibody Study (KAPS) group. Am J Clin Pathol 94(4):476\u2013484","journal-title":"Am J Clin Pathol"},{"issue":"8","key":"60_CR14","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1191\/096120301701549651","volume":"10","author":"A Voss","year":"2001","unstructured":"Voss A, Jacobsen S, Heegaard NH (2001) Association of beta2-glycoprotein I IgG and IgM antibodies with thrombosis and thrombocytopenia. Lupus 10(8):533\u2013538","journal-title":"Lupus"},{"issue":"7","key":"60_CR15","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1093\/clinchem\/42.7.1116","volume":"42","author":"EN Erickson Jr","year":"1996","unstructured":"Erickson EN, Jr., Najmey SS, Keil LB, El Kadi HS, DeBari VA (1996) Reference calibrators for IgG antibodies to beta2-glycoprotein I: preparation, properties and availability to investigators. Clin Chem 42(7):1116\u20131117","journal-title":"Clin Chem"},{"issue":"3","key":"60_CR16","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1161\/01.ATV.10.3.325","volume":"10","author":"W Palinski","year":"1990","unstructured":"Palinski W, Yla-Herttuala S, Rosenfeld ME, Butler SW, Socher SA, Parthasarathy S et\u00a0al. (1990) Antisera and monoclonal antibodies specific for epitopes generated during oxidative modification of low density lipoprotein. Arteriosclerosis 10(3):325\u2013335","journal-title":"Arteriosclerosis"},{"issue":"8798","key":"60_CR17","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/0140-6736(92)90926-T","volume":"339","author":"JT Salonen","year":"1992","unstructured":"Salonen JT, Yla-Herttuala S, Yamamoto R, Butler S, Korpela H, Salonen R et\u00a0al. (1992) Autoantibody against oxidised LDL and progression of carotid atherosclerosis. Lancet 339(8798):883\u2013887","journal-title":"Lancet"},{"issue":"22","key":"60_CR18","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1001\/archinte.1994.00420220105012","volume":"154","author":"M Puurunen","year":"1994","unstructured":"Puurunen M, Manttari M, Manninen V, Tenkanen L, Alfthan G, Ehnholm C et\u00a0al. (1994) Antibody against oxidized low-density lipoprotein predicting myocardial infarction. Arch Intern Med 154(22):2605\u20132609","journal-title":"Arch Intern Med"},{"issue":"1","key":"60_CR19","doi-asserted-by":"crossref","first-page":"60","DOI":"10.2337\/diab.44.1.60","volume":"44","author":"G Bellomo","year":"1995","unstructured":"Bellomo G, Maggi E, Poli M, Agosta FG, Bollati P, Finardi G (1995) Autoantibodies against oxidatively modified low-density lipoproteins in NIDDM. Diabetes 44(1):60\u201366","journal-title":"Diabetes"},{"issue":"3","key":"60_CR20","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1191\/096120300678828280","volume":"9","author":"O Vaarala","year":"2000","unstructured":"Vaarala O (2000) Antibodies to oxidised LDL. Lupus 9(3):202\u2013205","journal-title":"Lupus"},{"issue":"3","key":"60_CR21","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1006\/jaut.1994.1024","volume":"7","author":"J Vazquez-Mellado","year":"1994","unstructured":"Vazquez-Mellado J, Llorente L, Richaud-Patin Y, Alarcon-Segovia D (1994) Exposure of anionic phospholipids upon platelet activation permits binding of beta 2 glycoprotein I and through it that of IgG antiphospholipid antibodies. Studies in platelets from patients with antiphospholipid syndrome and normal subjects. J Autoimmun 7(3):335\u2013348","journal-title":"J Autoimmun"},{"issue":"11","key":"60_CR22","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1161\/01.ATV.12.11.1258","volume":"12","author":"JC Khoo","year":"1992","unstructured":"Khoo JC, Miller E, Pio F, Steinberg D, Witztum JL (1992) Monoclonal antibodies against LDL further enhance macrophage uptake of LDL aggregates. Arterioscler Thromb 12(11):1258\u20131266","journal-title":"Arterioscler Thromb"},{"issue":"7","key":"60_CR23","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1161\/01.ATV.15.7.990","volume":"15","author":"PA Kiener","year":"1995","unstructured":"Kiener PA, Rankin BM, Davis PM, Yocum SA, Warr GA, Grove RI (1995) Immune complexes of LDL induce atherogenic responses in human monocytic cells. Arterioscler Thromb Vasc Biol 15(7):990\u2013999","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"5","key":"60_CR24","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/00002281-200109000-00006","volume":"13","author":"PL Meroni","year":"2001","unstructured":"Meroni PL, Riboldi P (2001) Pathogenic mechanisms mediating antiphospholipid syndrome. Curr Opin Rheumatol 13(5):377\u2013382","journal-title":"Curr Opin Rheumatol"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-005-0060-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-005-0060-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-005-0060-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,9]],"date-time":"2020-04-09T22:24:22Z","timestamp":1586471062000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-005-0060-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,9,28]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2006,3]]}},"alternative-id":["60"],"URL":"https:\/\/doi.org\/10.1007\/s00296-005-0060-9","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,9,28]]}}}